BENGALURU, November 14, 2017 /PRNewswire/ --
Novo Nordisk, a global healthcare company with more than 90 years of innovation and leadership in diabetescare organized a diabetes awareness drive today at Vikasa Soudha in association with Karnataka State Government Employees Association.
(Photo: http://mma.prnewswire.com/media/603699/Novo_Nordisk_Diabetes_Awareness.jpg )
On the sidelines of the awareness drive, Anil Kumble, Changing Diabetes® ambassador, released the survey findings of the 'Diabetes and Women's Health' survey conducted by Novo Nordisk India in partnership with Kantar IMRB.
Amongst the dignitaries present at the event were Melvin Oscar D'souza, Managing Director, Novo Nordisk India; Dr. Shaila Bhattacharya, MD, MRCP, DM-(Endocrinology); BP Manje Gowda, Chairperson, Karnataka State Government Employees Association; Bharathi Shankar, Karnataka State Women's Development Corporation; and Ramesh Sanga, Vice President, Karnataka State Government NPS Employees Association.
The Novo Nordisk Kantar IMRB survey revealed that 65% of young women in urban areas are at increased risk of developing type 2 diabetes due to lack of exercise.
A total sample size of 1055 women, belonging to the age group of 18-65 years were interviewed to draw insights on the level of awareness on risks emerging from diabetes. The survey conducted across 14 cities in the country - Delhi, Mumbai, Bangalore, Kolkata, Hyderabad, Chennai, Ahmedabad, Bhubaneswar, Lucknow, Ludhiana, Indore, Guwahati, Kochi and Vijaywada, reflects that 78% women interviewed were aware of diabetes as a serious health concern and more than 70% women believed that a healthy lifestyle will help prevent diabetes and its associated complications.
Low physical activity coupled with poor eating habits and high-stress life, puts women in the reproductive age at risk of developing Gestational Diabetes Mellitus (GDM). Further, a study conducted by Prof. V Seshiah, Chairman, Dr. V Seshiah Diabetes Research Institute, Chennai, demonstrates that children born to women diagnosed with GDM are at increased risk of future diabetes due to 'gestational programming', wherein exposure to diabetes during foetal development predisposes the individual to diabetes later in adult life2.
"There is a clear need to build awareness about early diagnosis of diabetes and treatment initiation especially among women in the reproductive age group. Incorporating at least 30 minutes of exercise daily along with healthy eating habits is critical to preventing diabetes," said Dr. Shaila S Bhattacharyya, MD, MRCP, DM-(Endocrinology).
According to the International Diabetes Federation [IDF] 8th Atlas 2017, India is inching closer to overtake China to have the largest population of people with diabetes: 72.9 million are living with diabetes currently and is expected to grow upto 134.3 million by 2045 1. The atlas also points out that one in six births globally (16.2%) is affected by GDM. However, the Novo Nordisk-Kantar IMRB survey suggests that in India 73% of urban women are unaware of GDM and its related risks for next generation health.
"The data reflects that there is an imperative need for women to be aware of GDM and the responsibility also lies on the doctors to ensure that expecting mothers are educated about GDM. This will help raise healthier children," added Dr. Bhattacharya.
Corresponding with Dr. Shaila S Bhattacharya, Melvin D'souza, Managing Director, Novo Nordisk India said, "Women are the agents of change in every family and ensure that every family member eats healthy and follows a healthy lifestyle. While it is encouraging to note that 78% of the respondents were aware about diabetes and its complications, it is alarming to note that women are not taking concrete actions to address this challenge. The time has now come for the nation to collaborate and ACT (awareness, capacity building and treatment) against diabetes and safeguard next generation health. We as an organization are committed to change the Diabetes Barometer and will continue to work towards empowering women by providing knowledge, strengthening their capacity to manage type 2 diabetes in families, and thus making India a more diabetes-aware nation. At Novo Nordisk, we will continue to lead the war against diabetes."
About Novo Nordisk
Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. This heritage has given us experience and capabilities that also enable us to help people defeat obesity, haemophilia, growth disorders and other serious chronic diseases. Headquartered in Denmark, Novo Nordisk employs approximately 41,700 people in 77 countries and markets its products in more than 165 countries. For more information, visit: www.novonordisk.com, Facebook, Twitter, LinkedIn, YouTube
References 1. IDF 8th Atlas 2017 [http://www.diabetesatlas.org/] 2. Seshiah V, Balaji V, Balaji Madhuri S, Sanjeevi CB, Green A. Gestational diabetes mellitus in India. J Assoc Physicians India 2004;52:707.
For more information, please reach out to: Stuti Das +91-7899043410 email@example.com
Aishwarya Kar +91-8884703567 firstname.lastname@example.org Genesis Burson-Marsteller Public Relations Pvt. Ltd
Subscribe to our Free Newsletters!
Steroids are miracle drugs but have to be used with caution. Some steroids are illegal to use, ...
Abruptio placenta is a serious but rare complication of pregnancy where a separation of placenta ...
Cyanosis is the bluish or purplish discoloration of the skin and mucus membranes due to lack of ...View All